Bupivacaine HCl

Category
Local Anesthetic
Product code
18010-40-7

Bupivacaine HCl (Hydrochloride) is a long-acting amide-type local anesthetic active pharmaceutical ingredient widely used for surgical anesthesia and pain management. By reversibly blocking sodium ion influx in nerve fibers, Bupivacaine interrupts nerve signal transmission, producing effective sensory and motor blockade. Its prolonged duration of action makes it a preferred choice for procedures requiring extended anesthesia and for postoperative pain control. Pharmaceutical companies formulate Bupivacaine Hydrochloride into injectable solutions for infiltration, peripheral nerve blocks, epidural, and spinal anesthesia, offering clinicians flexible options across surgical and obstetric settings.

Common Aripiprazole Uses and Treated Conditions

  • Surgical Anesthesia – Provides local and regional anesthesia during surgical procedures.
  • Obstetric Anesthesia – Frequently used in epidural and spinal anesthesia for labor and cesarean delivery.
  • Postoperative Pain Management – Delivers prolonged analgesia following surgery.
  • Regional Nerve Blocks – Applied for peripheral nerve and field block anesthesia.

Why Choose Cambrex as Your Generic API Manufacturer?

As a leading generic API supplier, Cambrex manufactures Bupivacaine HCl API in cGMP-compliant facilities, ensuring every batch meets stringent global quality and regulatory standards. Our technical expertise, robust quality systems, and proven regulatory track record empower clients to accelerate development timelines and achieve successful market approvals. We prioritize transparency, reliability, and scientific rigor at every stage of the supply chain making us your trusted generic API manufacturer.

For detailed chemical information on Bupivacaine HCl, visit the official CAS webpage.

If you’d like more information or to request a sample, contact our Generic API team today.

Bupivacaine HCl

Cambrex your API partner

Cambrex are a leading global supplier of generic APIs. From our sites in Italy, Sweden, and the USA, we work with generic drug companies well in advance of drug patent expiration, using high quality, non-patent-infringing processes to manufacture APIs.

Contact us